The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.
Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.
Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.
Acacia Research Corporation
on its entry into an agreement with Link Fund Solutions Limited to purchase shares in up to 19 public and private life sciences companies from the LF Equity Income Fund for up to £223.9 million.
a company representing pharmaceutical wholesalers, on regulatory affairs and intellectual property matters
in relation to the launch and correct classification of new products based on a disruptive technology for extracting microRNA from plants, including advising on strategy to mitigate risks related to a misclassification under the contiguous categories of medicinal products, novel food and food supplements
assisting leading Italian vaccine-developer Achilles Vaccines on various projects, including the creation of a platform for streamlining the research and development of new vaccines (including against COVID-19) and the start of a collaboration with vAMRes Lab at Toscana Life Sciences (TLS) Foundation (based in Siena, Italy) on a research project for the development of human monoclonal antibodies against COVID-19, with the aim of using them for prophylactic/therapeutic purposes and as molecular baits for the discovery of vaccine antigens. We also advised on Italian and German finance, IP and regulatory aspects of its EUR 46 million venture loan financing from EMF EU Malaria Fund (a fund linked to EIB)
Advising Abbvie Inc., on the EU merger control aspects of its US$63 billion acquisition of Allergan
Sterling Pharma Solutions
Advising Sterling Pharma Solutions on its disposal of a UK based pharmaceutical manufacturing business by way of auction sale to GHO Capital
Alan specialises in public and private cross-border mergers and acquisitions, restructurings, joint ventures and partnership matters, acting for international corporates, investment banks and professional services firms.
Natalie is both an experienced Corporate and Mergers & Acquisitions lawyer and an expert in Healthcare, Aged Care, Outsourcing and Privatisations. Natalie is Herbert Smith Freehills’ Sector Lead Partner for Healthcare.